Apollo Therapeutics

Associate Sponsor

About Apollo Therapeutics 

Apollo Therapeutics, a biopharmaceutical company focused on translating breakthrough science from top global universities into differentiated medicines, is based in the US and UK. With five programs in clinical development and multiple preclinical programs, Apollo is building a diversified portfolio of novel therapeutics with uncorrelated risk. Apollo has a scalable R&D platform enabled by an unprecedented level of access to breakthroughs in biology and basic medical research made at six of the world's leading universities and research institutes. Apollo also in-licenses or acquires clinical-stage programs where it has unique insights and synergies. For more information, please visit www.apollotx.com.